ПРИМЕНЕНИЕ LIMK-1, ЕГО АНАЛОГОВ И ЛИГАНДОВ ДЛЯ ПОЛУЧЕНИЯ ЛЕКАРСТВЕННОГО ПРЕПАРАТА ПРОТИВ ТРОМБООБРАЗОВАНИЯ ИЛИ ЗАБОЛЕВАНИЯ С НАРУШЕННОЙ СВЕРТЫВАЕМОСТЬЮ КРОВИ

摘要

The present invention relates to LIMK-1, a LIMK-1-analogue or LIMK-1 ligand for the binding to GPIIb and/or activation or inhibition of GPIIb/IIIa downstream signaling, for the production of a medicament for the prevention or treatment of a thrombus formation or blood clotting disease, methods of screening method of screening a LIMK-1 analogue or a LIMK-1 ligand and a method for producing a medicament for the treatment of a thrombus formation or blood clotting disease.